Abbott Laboratories News Headlines

ABT 
$41.93
*  
0.03
0.07%
Get ABT Alerts
*Delayed - data as of Sep. 30, 2014 11:17 ET  -  Find a broker to begin trading ABT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ABT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Premature Combination Use Of Belviq And Phentermine Is A Risk
9/28/2014 9:27:00 AM - Seeking Alpha

Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - A Dreary September Update
9/28/2014 12:01:00 AM - Seeking Alpha

Abbott Laboratories ABT Announces Acquisition of CFR Pharmaceuticals
9/26/2014 1:10:00 PM - Dow Jones Business News

Abbott Labs Completes Acquisition Of Chile''s CFR Pharma In $2.9 Bln Deal
9/26/2014 10:41:00 AM - RTT News

3 Reasons AbbVie Inc Stock Could Fall
9/26/2014 10:17:13 AM - Motley Fool

Abbott Labs Acquires Control Of CFR Pharma - Quick Facts
9/26/2014 9:12:00 AM - RTT News

Will New Treasury Rules Contain Tax Inversions? - Analyst Blog
9/24/2014 10:22:00 AM - Zacks.com

Abbott Reports Expiration Of U.S. Tender Offer For CFR Pharma - Quick Facts
9/24/2014 9:12:00 AM - RTT News

Stocks Fall For U.S. Firms in Pending Inversion Deals After Treasury Move -- Update
9/23/2014 11:48:00 AM - Dow Jones Business News

Stocks Fall For U.S. Firms in Pending Inversion Deals
9/23/2014 11:45:00 AM - Dow Jones Business News

SSO, MMM, ABT, ABBV: ETF Inflow Alert
9/23/2014 11:44:01 AM - BNK Invest

Stocks Fall For U.S. Firms in Pending Inversion Deals After Treasury Move
9/23/2014 11:33:00 AM - Dow Jones Business News

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
9/22/2014 6:20:00 PM - Zacks.com

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
9/22/2014 4:45:00 PM - Zacks.com

Study Shows Medtronic's CoreValve TAVR Device Has Consistent And Cost Effective Performance
9/22/2014 2:02:20 PM - Trefis

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
9/19/2014 12:32:06 PM - Motley Fool

Abbott Labs (ABT) to Initiate New Trial on Absorb - Analyst Blog
9/17/2014 5:05:00 PM - Zacks.com

JNK, RXL: Big ETF Outflows
9/17/2014 12:03:37 PM - BNK Invest

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away
9/16/2014 2:01:00 PM - Seeking Alpha

10 Dividend Growth Stocks Giving Investors More Money
9/15/2014 11:16:00 PM - Seeking Alpha

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
9/15/2014 5:20:00 PM - Zacks.com

Update: Abbott To Invest $60 Million In An Intraocular Lens Plant In Malaysia
9/15/2014 3:00:00 PM - Seeking Alpha

Notable ETF Outflow Detected - SSO, MMM, ABT, ABBV
9/15/2014 1:04:55 PM - BNK Invest

Abbott Begins ABSORB IV Trial To Test Quality Of Life & Cost Savings Of BVS
9/15/2014 9:51:00 AM - RTT News

Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session - Tale of the Tape
9/15/2014 9:18:00 AM - Zacks.com